Early Phase
GCTRO has created a unique model for Early Phase Clinical Development which brings the expertise and experience of the West together with the cost effectiveness and efficient resources of the East. Now with our Strategic partnership with Hawaii Clinical Research Center, we have an experience of conducting over 150 Early Phase studies spanning over 20 years. Recently with the setting up of a CRU (Clinical Research Unit) in Delhi, India, we have positioned ourselves nicely to conduct Early Phase Clinical Studies (Phase I and II) at a very competitive price and controlling the quality, integrity, and accuracy of every aspect of the study.
Our Clinical Development services include an array of services like Clinical Research services supporting of Phase I-II Drug and Device Development, Clinical Monitoring Regulatory and Medical Support, investigator and Patient recruitment, Site Management, Biostatistics, Data Management, Drug Safety, Quality Assurance and Medical Writing .These services are available on a global scale and in an integrated model as the study is conducted on two different continents.
